London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Corneal anesthesia in childhood

Poster Details

First Author: M.Diab SAUDI ARABIA

Co Author(s):    S. Eissa              

Abstract Details

Purpose:

We present the largest reported series of children Corneal anesthesia (CA) in childhood carries a poor prognosis and there is little literature on its management with this rare disorder.

Setting:

Magrabi Hospital Aseer King Saudia Arabia

Methods:

We performed a retrospective chart review of children with congenital or acquired CA presenting to our institution over the last 15 years. Patients with concurrent facial nerve or other cranial nerve palsies were included.

Results:

21 eyes of 16 children were identified with CA caused by posterior fossa tumors (5), cerebellar hypoplasia (3), severe head trauma (3), familial dysautonomia (2) and isolated CA (3).The median follow-up 47.5 months. Six eyes in four children had final visual acuities (VA) of 20/40 or better. All eyes with VA 20/200 or worse at last follow-up had associated facial nerve palsy or isolated CA. Complications included corneal scarring (81%), infectious keratitis (48%),corneal neovascularization (48%) and perforation secondary to keratitis (5%). Four children underwent corneal grafting for perforation or scarring. All grafts became opaque,with VAs of 20/800 or worse

Conclusions:

Discussion: Isolated CA, and CA with CNVIIP, are associated with visual outcomes below 20/200. Earlier tarsorrhaphy Conclusion: We recommend that ophthalmologists suspect and test for CA in children with painless epithelial defects and consider early tarsorrhaphy may help preserve vision in these high-risk eyes.

Financial Disclosure:

NONE

Back to Poster listing